Cresset Asset Management »

Travere Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $138k 18k 7.71
2023-12-31 $162k 18k 8.99
2023-09-30 $168k 19k 8.94
2023-06-30 $285k 19k 15.36
2021-12-31 $222k 7.1k 31.10

More positions owned by Cresset Asset Management

Arista Networks Put Option (ANET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 100 Etf (OEF)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A Put Option (META)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation Put Option (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Cresset Asset Management

Top funds holding Travere Therapeutics

BlackRock
Armistice Capital
Deep Track Capital
Vanguard Group
Rock Springs Capital Management
Macquarie Group
State Street Corporation
Morgan Stanley
Millennium Management
Assenagon Asset Management
Renaissance Technologies
Kynam Capital Management
Jacobs Levy Equity Management
Bank of America Corporation
Geode Capital Management

View all funds holding Travere Therapeutics